Marker

(redirected from biomarker)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Marker

A slang term for documentation indicating that a debt is owed.
References in periodicals archive ?
An intended use of the biomarker may be in the clinical setting, where the focus is on the individual and there is an opportunity to gather substantial detailed information.
Biomarker Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to biomarker trends and structure of deals entered into by leading companies worldwide.
9 (Translational Biomarkers of Acute Drug Induced Liver Injury: The Current State, Gaps and Future Opportunities (Josef Ozer, William Reagan, Sheli Schomaker, Joe Palandra, Mike Baratta and Shashi Ramaiah)
Biomarker Partnering Terms and Agreements provides the reader with the following key benefits: In-depth understanding of biomarker deal trends since 2009 Access to headline, upfront, milestone and royalty data Analysis of the structure of over 700 biomarker agreements with numerous real life case studies Comprehensive access to over 50 actual biomarker contracts entered into by the world's biopharma companies Detailed access to actual biomarker contracts enter into by the leading fifty big pharma companies Insight into the terms included in a biomarker agreement, together with real world clause examples Understand the key deal terms companies have agreed in previous deals Undertake due diligence to assess suitability of your proposed deal terms for partner companies TABLE OF CONTENTS
Figure 8-2 Global Nervous System Disorder Biomarker Market by Application, Clinical versus Research 2008- 2018 Figure 8-3 Global Nervous System Disorder Biomarker Market Estimated Market Share by region (US, EMEA, Other), 2013 CHAPTER NINE: MARKET SUMMARY Table 9-1 The Global Medical Biomarker Market 2008-2018 Figure 9-1 The Global Medical Biomarker Market 2008-2018 Figure 9-2 The Global Medical Biomarker Market Estimated Market Share by Segment, 2013 Figure 9-3 The Global Medical Biomarker Market Estimated Market Share by Application, 2013 Figure 9-4 Global Medical Biomarker Market by Application, Clinical versus Research 2008-2018 Figure 9-5 The Global Medical Biomarker Market Estimated Market Share by Geographic Region, 2013 COMPANY PROFILES LIST OF CONTRIBUTORS
2 Biomarkers in Drug Discovery - Facilitating a Quick Turnaround Time: Overview
The -omics revolution of the last decade has ensured that the field of biomarker research will test the frontiers of biomedical research in the coming years with excellent growth prospects.
Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of biomarker deals as well as contract documents available in the public domain.
The majority of the CNS biomarker research at the present time is aimed at the discovery and identification of biomarker signatures through the application of gene expression profiling, protein profiling and/or metabolomics, as well as the use of imaging and electrophysiological surrogate biomarkers.
Addition of the Cira platform will strengthen and broaden our biomarker menu in the areas of oncology, pulmonary diseases, cardiovascular diseases, and a wide range of therapeutic areas involving inflammation.
The biomarker licensed to BG Medicine from ACS Biomarker was discovered by Professor Mat Daemen, who is one of the founders of ACS Biomarker and Scientific Director of CARIM.